Insurance companies announce genetic testing halt

A five-year moratorium on the use of genetic test results in the calculation of insurance premiums has provided some much needed breathing space.

Written byPat Hagan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LONDON — When it comes to the subject of genetic testing, insurance companies rarely get a good press. But the agreement between the UK Government and the Association of British Insurers (ABI) to implement a five-year moratorium, has undoubtedly cast the industry in a new light. During this period insurers will only request genetic information on certain diseases where the policies involve large amounts of cover. For its part, the government will not bring forward restrictive legislation.

The idea is that the moratorium will provide a breathing space for all parties to disentangle the ethics of a vexed situation. In the meantime, the ABI will monitor whether insurers are complying with the voluntary rules agreed between themselves and the Department of Health.

These state that from 1 November 2001 insurers will not take genetic data into consideration when evaluating premiums unless the government's Genetics and Insurance Committee has approved the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery